Contact Person : Lisa Scimemi; Last Date for the submission of abstract : Not Available ; Description : Includes: Harnessing NK cells for new adoptive cell therapies, advances in adoptive T-cell therapy, emerging strategies for checkpoint combination therapy, novel targets for immunotherapy development and synergistic combinations.